US › Healthcare

Addex Therapeutics Ltd (ADXN)

US · Healthcare · Biotechnology

$3.360.00%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$7,691

Revenue YoY

+410.0%

Net profit

$-1.7M

EPS

$-1.33

Net margin

-22,256.4%

Key statistics

Market cap

$4.4M

Forward P/E

0.0

P/B

1.13

Book value

$4.15

EPS (TTM)

$-8.89

52-week high

$11.97

52-week low

$3.30

50-day MA

$5.19

200-day MA

$6.65

Beta

1.96

Analyst view

Analysts rate Addex Therapeutics Ltd a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $30.00.

Shareholding

Institutions

0.01%

Largest institutional holders

Fund	Stake
Morgan Stanley - Brokerage Accounts	0.03%
Rhumbline Advisers	0.01%
SBI Securities Co Ltd	0.00%
GAMMA Investing LLC	0.00%
UBS Group AG	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Addex Therapeutics Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.